Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice

被引:21
|
作者
Sun, Xiujie [1 ]
Gupta, Kshama [1 ]
Wu, Bogang [1 ]
Zhang, Deyi [1 ]
Yuan, Bin [1 ]
Zhang, Xiaowen [1 ]
Chiang, Huai-Chin [1 ]
Zhang, Chi [1 ]
Curiel, Tyler J. [1 ]
Bendeck, Michelle P. [2 ]
Hursting, Stephen [3 ]
Hu, Yanfen [1 ]
Li, Rong [1 ]
机构
[1] Univ Texas Hlth San Antonio, Dept Med, Dept Mol Med, San Antonio, TX 78229 USA
[2] Univ Toronto, Ted Rogers Ctr Heart Res, Toronto, ON M5G 1M1, Canada
[3] Univ N Carolina, Nutr Res Inst, Dept Nutr, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
BREAST-CANCER CELLS; MESENCHYMAL TRANSITION; TYROSINE KINASES; CLAUDIN-LOW; BASAL-LIKE; OBESITY; INFLAMMATION; PROGRESSION; EXPRESSION; TISSUE;
D O I
10.1074/jbc.RA117.000672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Discoidin domain receptor 1 (DDR1) is a collagen receptor that mediates cell communication with the extracellular matrix (ECM). Aberrant expression and activity of DDR1 in tumor cells are known to promote tumor growth. Although elevated DDR1 levels in the stroma of breast tumors are associated with poor patient outcome, a causal role for tumor-extrinsic DDR1 in cancer promotion remains unclear. Here we report that murine mammary tumor cells transplanted to syngeneic recipient mice in which Ddr1 has been knocked out (KO) grow less robustly than in WT mice. We also found that the tumor-associated stroma in Ddr1-KO mice exhibits reduced collagen deposition compared with the WT controls, supporting a role for stromal DDR1 in ECM remodeling of the tumor microenvironment. Furthermore, the stromal-vascular fraction (SVF) of Ddr1 knockout adipose tissue, which contains committed adipose stem/progenitor cells and preadipocytes, was impaired in its ability to stimulate tumor cell migration and invasion. Cytokine array-based screening identified interleukin 6 (IL-6) as a cytokine secreted by the SVF in a DDR1-dependent manner. SVF-produced IL-6 is important for SVF-stimulated tumor cell invasion in vitro, and, using antibody-based neutralization, we show that tumor promotion by IL-6 in vivo requires DDR1. In conclusion, our work demonstrates a previously unrecognized function of DDR1 in promoting tumor growth.
引用
收藏
页码:2841 / 2849
页数:9
相关论文
共 47 条
  • [21] Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice
    Gehrke, Nadine
    Hofmann, Lea J.
    Straub, Beate K.
    Ridder, Dirk A.
    Waisman, Ari
    Kaps, Leonard
    Galle, Peter R.
    Schattenberg, Joern M.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (12)
  • [22] PRODUCTION OF INTERLEUKIN-6 IN HUNAN OSTEOBLASTS AND HUMAN BONE-MARROW STROMAL CELLS - EVIDENCE THAT INDUCTION BY INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IS NOT REGULATED BY OVARIAN-STEROIDS
    RIFAS, L
    KENNEY, JS
    MARCELLI, M
    PACIFICI, R
    CHENG, SL
    DAWSON, LL
    AVIOLI, LV
    ENDOCRINOLOGY, 1995, 136 (09) : 4056 - 4067
  • [23] Activin-A is induced by interleukin-1β and tumor necrosis factor-α and enhances the mRNA expression of interleukin-6 and protease-activated receptor-2 and proliferation of stromal cells from endometrioma
    Yoshino, Osamu
    Izumi, Gentaro
    Shi, Jia
    Osuga, Yutaka
    Hirota, Yasushi
    Hirata, Tetsuya
    Harada, Miyuki
    Nishii, Osamu
    Koga, Kaori
    Taketani, Yuji
    FERTILITY AND STERILITY, 2011, 96 (01) : 118 - 121
  • [24] Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells
    Nguyen, N
    Kuliopulos, A
    Graham, RA
    Covic, L
    CANCER RESEARCH, 2006, 66 (05) : 2658 - 2665
  • [25] Platelet Activating Factor Receptor in stromal cells promotes B16F10 melanoma cell tumor growth in vivo through an Interleukin 10-dependent mechanism: Potential role of systemic immunosuppression
    Sahu, Ravi P.
    Travers, Jeffrey B.
    Konger, Raymond L.
    FASEB JOURNAL, 2011, 25
  • [26] CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling
    Qiu, Bai-Quan
    Zhang, Peng-Fei
    Xiong, Dian
    Xu, Jian-Jun
    Long, Xiang
    Zhu, Shu-Qiang
    Ye, Xu-Dong
    Wu, Yin
    Pei, Xu
    Zhang, Xue-Mei
    Wu, Yong-Bing
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 11256 - 11264
  • [27] Interleukin-6 and tumor necrosis factor-α type 1 receptor deficient mice reveal a role of IL-6 and TNF-α on brain metallothionein-I and -III regulation
    Carrasco, J
    Hernandez, J
    Bluethmann, H
    Hidalgo, J
    MOLECULAR BRAIN RESEARCH, 1998, 57 (02): : 221 - 234
  • [28] Erythropoietin-producing hepatocyte kinase receptor A1 facilitating the prgression of SGC-7901 cells and its transplanted tumor by increasing the expression of interleukin-6 and vascular endothelial growth factor in tumor microenvironment
    Wang, Yong-Cang
    Zheng, Wen-Lin
    Yu, Wei
    Quan, Rui-Liang
    Zhao, Ya-Jun
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [29] Erythropoietin-producing hepatocyte kinase receptor A1 facilitating the prgression of SGC-7901 cells and its transplanted tumor by increasing the expression of interleukin-6 and vascular endothelial growth factor in tumor microenvironment
    Wang, Yong-Cang
    Zheng, Wen-Lin
    Yu, Wei
    Quan, Rui-Liang
    Zhao, Ya-Jun
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [30] LACTOFERRIN RELEASE AND INTERLEUKIN-1, INTERLEUKIN-6, AND TUMOR-NECROSIS-FACTOR PRODUCTION BY HUMAN POLYMORPHONUCLEAR CELLS STIMULATED BY VARIOUS LIPOPOLYSACCHARIDES - RELATIONSHIP TO GROWTH-INHIBITION OF CANDIDA-ALBICANS
    PALMA, C
    CASSONE, A
    SERBOUSEK, D
    PEARSON, CA
    DJEU, JY
    INFECTION AND IMMUNITY, 1992, 60 (11) : 4604 - 4611